Ascletis Pharma (HKSE:01672) FCF Yield % : -15.55 (As of Dec. 12, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ascletis Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ascletis Pharma's Trailing 12-Month Free Cash Flow is HK$-312.62 Mil, and Market Cap is HK$2,010.42 Mil. Therefore, Ascletis Pharma's FCF Yield % for today is -15.55%.

The historical rank and industry rank for Ascletis Pharma's FCF Yield % or its related term are showing as below:

HKSE:01672' s FCF Yield % Range Over the Past 10 Years
Min: -21.32 Med: -4.82 Max: -2.28
Current: -15.55

During the past 8 years, the highest FCF Yield % of Ascletis Pharma was -2.28%. The lowest was -21.32%. And the median was -4.82%.

HKSE:01672's FCF Yield % is ranked worse than
53.88% of 1507 companies
in the Biotechnology industry
Industry Median: -12.65 vs HKSE:01672: -15.55

Ascletis Pharma's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

Ascletis Pharma FCF Yield % Historical Data

The historical data trend for Ascletis Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascletis Pharma FCF Yield % Chart

Ascletis Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-3.47

-4.63

-5.24

-4.70

-11.73

Ascletis Pharma Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Yield %	Get a 7-Day Free Trial											-6.37	-4.55	-8.50	-12.11	-54.41

Competitive Comparison of Ascletis Pharma's FCF Yield %

For the Biotechnology subindustry, Ascletis Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascletis Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascletis Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ascletis Pharma's FCF Yield % falls into.

Ascletis Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ascletis Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-178.636	/	1522.3712
	=	-11.73%

Ascletis Pharma's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-220.431	*	2	/	810.2
	=	-54.41%

Ascletis Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Ascletis Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Ascletis Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascletis Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascletis Pharma Inc (HKSE:01672) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

ASCLF:USA 2VJ:Germany

Address

198 Qidi Road, 12th Floor, Building D, HIPARK, Xiaoshan District, Zhejiang Province, Hangzhou, CHN, 311200

Website

https://www.ascletis.com

Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. Ritonavir tablets, GANOVO, and ASCLEVIR. It also has other drug candidates in its pipeline in their different stages of development such as ASC22, ASC10, ASC11, and ASC40 among others. Geographically, it operates in Mainland China and other countries.

Executives

Jjw12 Limited
Lakemont Holding Llc
Wu Jinzi Jason	2101 Beneficial owner
Wu Judy Hejingdao	2101 Beneficial owner
Jjw11 Limited
C-bridge Capital Gp, Ltd.	2201 Interest of corporation controlled by you
Fu Wei	2201 Interest of corporation controlled by you
Tf Capital Ii Ltd.	2201 Interest of corporation controlled by you
Tf Capital, Ltd.	2201 Interest of corporation controlled by you
Kang Hua Investment Company Limited	2201 Interest of corporation controlled by you
Yang Dan	2201 Interest of corporation controlled by you

Ascletis Pharma Headlines

No Headlines